Oct 11, 2021 | Corona virus, Patient's Guide
The treatment of COVID-19 Monoclonal antibody sotrovimab Assist. Prof. Aleksandra Maršavelski, PhD Specialist in computational biochemistry * Monoclonal antibody sotrovimab receives Emergency Use Authorization from the US FDA for the treatment of COVID-19 ...
Oct 6, 2021 | Corona virus, Immunology, Patient's Guide
Llama antibodies have great potential in the fight against COVID-19 A treatment consisting of “nanobodies,” small, simpler versions of antibodies, naturallyproduced by llamas in response to infection have great potential in the treatment of COVID-19. In a study...
Oct 6, 2021 | Corona virus, Immunology, Patient's Guide
COVID-19 and vaccination against it *COVID-19 mutations and variants – Dr. sc. Sanja NovakResearch Instructor, Department of Reconstructive Sciences, University of Connecticut, US Since SARS-CoV-2 was first identified in China, thousands of mutations have been...
Sep 30, 2021 | Corona virus
Infertility and vaccines – a lie from social networks COVID-19 VACCINE MYTHS DEBUNKED Not only is there no evidence that vaccines cause fertility problemsin men or women, but experts say there’s no realistic way they could.Claims to the contrary on social...
Sep 29, 2021 | Corona virus
WHY SARS-COV-2 STRAINS AREMORE INFECTIOUS THANSARS-COV-1 The first step in coronavirus infection is theentry of the virus into the host cells. Scientists revealed the “inactive” and”active” states of the spike proteins of both theSARS-CoV-1 and...
Sep 28, 2021 | Corona virus, Immunology, protection
Pfizer unveils oral inhibitorPF-07321332 of SARS-CoV-2 main protease Pfizer presented at a meeting of the AmericanChemical Society a potential anti-SARS-CoV-2 drug (PF-07321332), the firstorally administered coronavirus-specific protease inhibitor. CompoundPF-07321332...
Recent Comments